AUGMENTIN™ in Dental Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

March 21, 2013

Primary Completion Date

December 28, 2013

Study Completion Date

December 28, 2013

Conditions
Focal Infection, Dental
Interventions
DRUG

Amoxicillin/clavulanate

Amoxicillin/clavulanate 1 g bd for at least 5 days or maximum 7 days depending upon the treatment response.

DRUG

Clindamycin

Clindamycin 150 mg qid for at least 5 days or maximum 7 days depending upon the treatment response.

Trial Locations (15)

1100

GSK Investigational Site, Quezon

1109

GSK Investigational Site, Quezon

6000

GSK Investigational Site, Cebu

8000

GSK Investigational Site, Davao City

31350

GSK Investigational Site, Perak

50050

GSK Investigational Site, Kuala Lumpur

52000

GSK Investigational Site, Lampang

68100

GSK Investigational Site, Kuala Selangor

77120

GSK Investigational Site, Pran Buri

90112

GSK Investigational Site, Songkhla

62250,

GSK Investigational Site, Putrajaya

Hoan Kiem District

GSK Investigational Site, Hanoi

District 10

GSK Investigational Site, Ho Chi Minh City

District 1

GSK Investigational Site, Ho Chi Minh City

District 5

GSK Investigational Site, Ho Chi Minh City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02141217 - AUGMENTIN™ in Dental Infections | Biotech Hunter | Biotech Hunter